Navigation Links
China Sky One Medical to Attend Investment Conferences in May
Date:5/13/2010

HARBIN, China, May 13 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that Mr. Stanley Hao, the Company's Chief Financial Officer, will participate in the following investor conferences in May 2010.

    CCG China Rising Investment Conference
    Time:            Monday, May 17, 2010
    Presentation:    4:00 pm ET
    Location:        Grand Hyatt New York, 109 East 42nd Street, New York

    Brean Murray, Carret & Co. 2010 Life Sciences Summit
    Time:            Monday, May 17, 2010
    Location:        Grand Hyatt New York, 109 East 42nd Street, New York

    Oppenheimer China Dragon Call Conference
    Time:            May 18, 2010
    Presentation:    10:00 am ET
    Location:        300 Madison Avenue, 3rd Floor, New York

Management will be available for one-on-one meetings with investors at the conferences. Please contact the respective representatives for each conference to set up the meetings.

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First
'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. China Biologic Products to Build Two New Plasma Stations in Shandong Province
2. China Nepstar Chain Drugstore Reschedules First Quarter 2010 Results to May 18
3. China Yongxin Pharmaceuticals is Selected as one of the Qualified Pharmaceutical Distributors for Jilin Province
4. China Pharma Holdings, Inc. Announces May Investor Conference Participation
5. China Nepstar Chain Drugstore Reports First Quarter 2010 Results on May 19
6. China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and the Fiscal Year Ended March 31, 2010 on June 4, 2010
7. China Pharma Holdings, Inc. Retains CCG Investor Relations
8. China Medical Technologies to Participate in Investor Conferences in May and June 2010
9. Winner Medical Participates in CMEF 2010, China International Medical Equipment Fair, in Shenzhen
10. Lotus Pharmaceuticals to Exhibit at the 63rd PHARMCHINA
11. China Sky One Medical Prepares to Launch 13 New Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2010)... DALLAS, Texas, September 2, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; ... first one. for (var r in data.results) { first_result = data.results[r]; break; } for ...
(Date:9/2/2010)... Schein, Inc. (Nasdaq: HSIC ), the ... to office-based practitioners, is helping a record number ... and carrying backpacks filled with school supplies and ... Back-to-School program.  This year, the Back-to-School program is ... and Canadian cities.  Since its creation in 1998, ...
(Date:9/1/2010)... CITY, Fla., Sept. 1 Gulf Coast ... of Radiology-accredited radiation oncology center, introduces the Elekta ... at the center,s Open House on Thursday, September ...  Gulf Coast Cancer Treatment Center (GCCTC) is located ... oncologists Dr. D.B. Hurst and Dr. Jefferson Trupp ...
Breaking Medicine Technology:Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 2Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 3Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 4Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 5Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 6Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 7Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 813th Annual Henry Schein Back-to-School Program Serves Record Number of Children 213th Annual Henry Schein Back-to-School Program Serves Record Number of Children 3Open House at Gulf Coast Cancer Treatment Center Introduces Elekta Synergy® to Community 2ApexTwo and SugarCRM Announce New Implementation Partnership 71891 1ApexTwo and SugarCRM Announce New Implementation Partnership 71891 2 2418 5 Million New Jersey Medical Malpractice Birth Injury Verdict Due To Cerebral Palsy Caused By A Delayed C Section 71887 1 2418 5 Million New Jersey Medical Malpractice Birth Injury Verdict Due To Cerebral Palsy Caused By A Delayed C Section 71887 2Cost Savings from Mobile Health Monitoring to Reach 241 9 billion to 245 8 Billion Globally by 2014 says Juniper Research 71883 1Cost Savings from Mobile Health Monitoring to Reach 241 9 billion to 245 8 Billion Globally by 2014 says Juniper Research 71883 2Cost Savings from Mobile Health Monitoring to Reach 241 9 billion to 245 8 Billion Globally by 2014 says Juniper Research 71883 3
... is Prostate Cancer Awareness Month, MIAMI and PALM ... Month, and the CyberKnife Centers of Miami and,Palm Beach ... surgery and long treatment courses of radiation. Prostate cancer ... the US., Morse CyberKnife CEO, James G. Schwade, ...
... N.Y., Sept. 2 The many recent reports,documenting ... in,animal models of human disease may actually be ... siRNA to activate an immune,response, according to a ... 9) of ,Human Gene Therapy, a peer-reviewed journal ...
Other Medicine Technology:Previous Claims of siRNA Therapeutic Effects Called into Question by Report in 'Human Gene Therapy' 2Previous Claims of siRNA Therapeutic Effects Called into Question by Report in 'Human Gene Therapy' 3
(Date:9/2/2010)... Dotinga HealthDay Reporter , , THURSDAY, Sept. 2 ... news stories about the young, possibly because it makes ... , , "The more time they spent with negative news ... may get some self-esteem boost out of this," said ... State University,s School of Communication. As for young ...
(Date:9/2/2010)... of as trunks in the tree of life. All multi-cellular ... variety other cellskidney, brain, heart or skin, for example. One ... virtually any cell type in the body, making them a ... of age-old diseases or even regrowing defective body parts. , ... shown for the first time that a gene called Myc ...
(Date:9/2/2010)... emergency medical services (EMS) agencies from across the country ... a tool that might point to potential patient safety ... School of Medicine. , The study , ... Prehospital Emergency Care and now available online, analyzed ... and Canada. Researchers adapted a survey used in other ...
(Date:9/2/2010)... treatments build on the benefits of drug therapy, ... and Dr. Kenneth Holroyd from Ohio University in ... various treatment combinations for severe migraine drug ... that those patients receiving the behavioral management program ... their ability to use behavioral skills to effectively ...
(Date:9/1/2010)... New research from the University of New Hampshire ... teenagers who use marijuana are more likely to move ... is overblown. , Whether teenagers who smoked pot ... more to do with life factors such as employment ... fact, the strongest predictor of whether someone will use ...
Breaking Medicine News(10 mins):Health News:Seniors Get Boost From Bad News About the Young 2Health News:Study finds that cancer-causing gene crucial in stem cell development 2Health News:Study finds that cancer-causing gene crucial in stem cell development 3Health News:Safety cultures in EMS agencies vary widely, Pitt study finds 2Health News:Head start for migraine sufferers 2Health News:Risk of marijuana's 'gateway effect' overblown, new UNH research shows 2
... a rate not seen in more than twenty years, creating a ... for small business is being called a top priority at a ... (NFIB) and America,s Health Insurance Plans (AHIP). , ... ...
... benefits can last for years, researchers say , , MONDAY, March ... play: A new study finds the pastime can help adults ... the first parts of vision to be affected by aging. ... minor changes in shades of grey against a uniform background ...
... 44% Over Prior YearVANCOUVER, March 30 /PRNewswire-FirstCall/ - Response ... recorded total revenues of $5,876,337 and a net loss ... ended December 31, 2008. Additionally, the Company announced that ... million in working capital. For a further discussion of ...
... offer improved aesthetic results will help drive the dental ... Mass., March 30 According to Millennium Research Group,s ... Implants 2009 report, although the current economic crisis ... term, the US dental implant market will recover after ...
... ANN ARBOR, Mich., March 30 A ... effective, cheaper medications may create barriers that lead people ... Thomson Reuters study. As a result, patients ultimately require ... called "step therapy," requires health plan members to try ...
... Well Tolerated Throughout Two-Year Study- Conference Call Scheduled ... March 30, 2009 Arena Pharmaceuticals, Inc. (Nasdaq: ... results from BLOOM (Behavioral modification and Lorcaserin for ... pivotal trials evaluating the safety and efficacy of ...
Other Medicine News:Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 2Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 3Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 4Health News:Response Biomedical Corporation Reports 2008 Financial Results 2Health News:Response Biomedical Corporation Reports 2008 Financial Results 3Health News:Response Biomedical Corporation Reports 2008 Financial Results 4Health News:Response Biomedical Corporation Reports 2008 Financial Results 5Health News:Dental Implant Market to Exceed $1 Billion by 2013 Despite Current Economic Slowdown 2Health News:Thomson Reuters Study Finds Step Therapy Programs May Increase Overall Healthcare Costs for Employers 2Health News:Thomson Reuters Study Finds Step Therapy Programs May Increase Overall Healthcare Costs for Employers 3Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 2Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 3Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 4Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 5Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 6Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 7Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 8Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 9Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 10Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 11
Finstruments 96 well washer and Cellwasher. Multi-function with touch programmable display....
The Finstrip combines high performance and flexibility with reliability, simplicity and ease of use....
... has set a standard for ultra-fast washing ... instrument not only processes all 384 wells ... further boost wash performance. This wash procedure ... times as no transport steps to index ...
... Bio-Rad's Model 1575 immunowash ... control of needle position ... routines and maximize wash ... a large choice of ...
Medicine Products: